论文信息 - Advances in anti-angiogenic agents for ovarian cancer treatment: The role of trebananib (AMG 386). - 字舞流文

Advances in anti-angiogenic agents for ovarian cancer treatment: The role of trebananib (AMG 386).

M. Gasparri | I. Ruscito | A. Farooqi | C. Marchetti | L. Muzii | P. Panici | I. Palaia | G. Perniola | F. Pecorini | A. Carrone